Guggenheim Capital’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Guggenheim Capital’s Portfolio CVRS Stock Details CVRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-31,699	Closed	-$43K	–	2737
2018 Q1	$43K	Sell	31,699 -791	-2%	-$918	﹤0.01%	2713
2017 Q4	$33K	Sell	32,490 -3,987	-11%	-$4.51K	﹤0.01%	2653
2017 Q3	$55K	Buy	36,477 +13,228	+57%	+$22.2K	﹤0.01%	2698
2017 Q2	$43K	Buy	23,249 +796	+4%	+$1.06K	﹤0.01%	2745
2017 Q1	$30K	Buy	+22,453	New	+$18.3K	﹤0.01%	2756

Other funds holding CVRS

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

PVAM

Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Guggenheim Capital's CVRS Position: Q2 2018 in Review

Guggenheim Capital sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 31,699 shares — an estimated $43K sold.

Guggenheim Capital first reported a position in CVRS in Q1 2017 and held it in 5 quarters. The position peaked at $55K in Q3 2017. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

Guggenheim Capital reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 31,699 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018, an estimated $43K.
Guggenheim Capital first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2017 and held it in 5 quarters.
Guggenheim Capital's CORINDUS VASCULAR ROBOTICS, INC position peaked at $55K in Q3 2017.
53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.